3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

SGLT2i Show Cardiorenal, Liver Benefits in Cirrhosis

In patients with type 2 diabetes and cirrhosis, SGLT2 inhibitors show increased efficacy over DPP-4 inhibitors in kidney, cardiac, and liver outcomes.

Stroke Support System Linked to Fewer Vascular Events

An AI-assisted clinical decision-support system is associated with reduced incidence of vascular events in patients with acute ischemic stroke, a new study shows.

12 Common Hypertension Pitfalls and How to Fix Them

A review identifies 12 common hypertension errors, highlighting missed diagnostic steps and treatment gaps that may affect long-term cardiovascular outcomes.

All-RISE, FAST III: Novel FFR Noninferior to Standard

Two trials showed novel angiography-based physiology assessments were comparable to pressure wire-based approaches for guiding percutaneous coronary intervention.

Sirolimus-Coated Balloon Reduces PAD Amputation Risk

Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse events in the SirPAD trial.

Incidental Liver Lesions Common in Patients With CHD on cMRI

Nearly 10% of patients with congenital heart disease have incidental liver lesions detected during cardiac MRI, the majority of which being previously unknown to clinicians.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Latest News

In patients with type 2 diabetes and cirrhosis, SGLT2 inhibitors show increased efficacy over DPP-4 inhibitors in kidney, cardiac, and liver outcomes.

An AI-assisted clinical decision-support system is associated with reduced incidence of vascular events in patients with acute ischemic stroke, a new study shows.

A review identifies 12 common hypertension errors, highlighting missed diagnostic steps and treatment gaps that may affect long-term cardiovascular outcomes.

Two trials showed novel angiography-based physiology assessments were comparable to pressure wire-based approaches for guiding percutaneous coronary intervention.

Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse events in the SirPAD trial.

Nearly 10% of patients with congenital heart disease have incidental liver lesions detected during cardiac MRI, the majority of which being previously unknown to clinicians.

News All Time

Indoor Air Pollution Linked to Inflammation in Heart Failure

Indoor air pollutants are associated with changes in inflammatory markers and cardiac autonomic dysregulation in people with heart failure.

5 Factors May Predict Stroke Risk Years After First Event

A new study finds hypertension, smoking history, and three ischemic stroke subtypes are linked to increased secondary stroke risk years after patients had their first minor stroke event.

Care Continuity With GPs May Improve Hypertension Detection

Continuity of care in general practice shows a dose-dependent link to higher rates and earlier detection of hypertension in adults without existing heart conditions.

FDA Okays Orforglipron for Weight Management

Eli Lilly’s orforglipron approved for adults with obesity or overweight with at least one comorbidity.

NICE Endorses Semaglutide to Reduce Cardiovascular Risk

Semaglutide recommended for NHS use in England to reduce heart attack and stroke risk in high-risk adults.

Early Acoramidis Yields Long-Term Gains in ATTR-CM

Early and continuous treatment with acoramidis is linked to lower risks for death and heart-related hospitalization than delayed treatment in patients with transthyretin amyloid cardiomyopathy.

AI Tool Predicts LDL Without Direct Testing

A machine learning model predicts low-density lipoprotein cholesterol from routine lab data, offering a low-cost way to identify high-risk patients.

Outdated Equipment Poses Health Risks in Fluoroscopy Labs

Is protecting clinicians actually causing harm? Experts call for a rethinking of radiation safety that also tackles the physical toll of protective gear.

From Prediabetes to CVD in 20 Years: The Risk Gets Real

People with impaired fasting glucose levels face a higher risk for cardiovascular diseases and the onset of diabetes than those with normal fasting glucose levels.

Sleeve Gastrectomy Tied to Improved Vascular Markers

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening.

Proposed Act Would Fill Gaps in Cancer Survivorship Care

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Low-Dose Aspirin Underutilized as Preeclampsia Prevention

Women at high risk for preeclampsia often do not receive recommended preventive treatment.

EU Widens Access for Rare Lipid and Obesity Disorders

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Even Low HIV Load Can Double Heart Disease Risk

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

Health Risk May Vary by Alcohol Type

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

PCI Reduces Symptoms of Chronic Total Occlusion

A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

Recommended News For You

Q&A: When will individuals be able to receive customized cancer vaccines?

An Intimate Life of Medical Innovation and Charity.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

An inadvertent loss of weight may be an indication to consult a physician, according to research.

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Is Exercise an Effective Treatment for Prostate Cancer?

The Cherenkov color image shows the possibility of improving the quality of radiation therapy.

Recommended Articles For You

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review 

The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder  

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

2.

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

3.

Healthcare in the Mix in President Biden's Farewell Address

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Next Day Mood Is Affected by Ability to Recover From Work.

1.

Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies

2.

Leukemia: Understanding the Disease and Its Impact on Patients 

3.

Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates

4.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

5.

Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

2.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot